QQ客服 官方微博 反馈留言

	Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303.
	Si Xiaoyan; Zhang Li; Wang Hanping; Zhang Xiaotong; Wang Mengzhao; Han Baohui; Li Kai; Wang Qiming; Shi Jianhua; Wang Zhehai
刊名	Thoracic cancer
	2019
卷号	10页码:551-556
关键词	non-small cell lung cancer multi-target tyrosine kinase inhibitor Adverse event anlotinib
ISSN号	1759-7714
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2828477
专题	西安交通大学
推荐引用方式 GB/T 7714	Si Xiaoyan,Zhang Li,Wang Hanping,et al. Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303.[J]. Thoracic cancer,2019,10:551-556.
APA	Si Xiaoyan.,Zhang Li.,Wang Hanping.,Zhang Xiaotong.,Wang Mengzhao.,...&Jin Faguang.(2019).Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303..Thoracic cancer,10,551-556.
MLA	Si Xiaoyan,et al."Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303.".Thoracic cancer 10(2019):551-556.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。